Publications

Journal Article Ppublish

PubMed: 39508590 DOI: 10.1128/aac.01363-24

Reply to Boyd et al., "Evidence that remdesivir treatment reduces viral titers in patients with COVID-19".

Antimicrob Agents Chemother 68(12):e0136324

Authors: Isa Faghihi, Victoria C Yan

Affiliations

  • University of Texas Southwestern Medical Center, Dallas, Texas, USA.

MeSH

Drug Therapy, Covid-19, Therapeutics, Anti-Bacterial Agents, Antiviral Agents